New drug MB0151 targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This study tests a new drug called MB0151 in adults with advanced solid tumors, including certain lung, breast, and neuroendocrine cancers. The goal is to check the drug's safety and see if it can shrink or control tumors. About 156 participants will receive the drug intravenousl…
Phase: PHASE1, PHASE2 • Sponsor: Mainline Biosciences (Shanghai) Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC